Thomas Sciascia serves as Executive at PENWEST PHARMACEUTICALS CO, where they oversee executive responsibilities. Since joining the company, Thomas Sciascia has executed 12 insider transactions totaling $272.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 19, 2024 involved selling 16,496 shares valued at $48.8K.
Thomas Sciascia currently holds 220,315 shares of PENWEST PHARMACEUTICALS CO (PPCO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Sciascia has been a net seller of PPCO stock. They have purchased $0 and sold $272.3K worth of shares.
Thomas Sciascia's most recent insider trade was on Aug 19, 2024, when they sold 16,496 shares at $2.96 per share.
Get notified when new Form 4 filings are submitted
| $1.43 |
| Discretionary |
| Aug 16, 2024 | TRVI | $51.5K | Sale | 18,660 | $2.76 | Discretionary |
| Aug 16, 2024 | TRVI | $26.7K | Option Exercise | 18,660 | $1.43 | Discretionary |
| Aug 15, 2024 | TRVI | $35.6K | Sale | 12,745 | $2.79 | Discretionary |
| Aug 15, 2024 | TRVI | $18.2K | Option Exercise | 12,745 | $1.43 | Discretionary |
| Aug 14, 2024 | TRVI | $143 | Option Exercise | 100 | $1.43 | Discretionary |
| Aug 14, 2024 | TRVI | $275 | Sale | 100 | $2.75 | Discretionary |
| May 29, 2024 | TRVI | $130.0K | Option Exercise | 59,354 | $2.19 | Discretionary |
| May 29, 2024 | TRVI | $136.1K | Sale | 53,368 | $2.55 | Discretionary |
| May 9, 2019 | TRVI | $0 | Conversion | 17,118 | $N/A | Discretionary |
| Sep 20, 2010 | PPCO | $0 | Tender | 40,494 | $N/A | Discretionary |